Name

tgDCC-E1A

Alternate Names

None

Abbreviations

None

Category

Biologic therapy (BRM, immunotherapy)

Subcategory

Gene therapy

NSC Number

None

Primary Site

Head & neck
ovarian cancer

Histology

None

Remarks

Phase II E1A tumor suppressor gene therapy. Targeted Genetics.

Coding

This drug should be coded
Glossary